Dabur India's plans to launch an Ayurvedic skincare range in the last quarter of this year could be pushed back by a few months, the FMCG company acquired Fern Care Pharma for more than Rs 203 crore and plans to make Fern its fifth major brand, Mr Sunil Duggal, CEO, Dabur India, is believed to have explained to investors in a conference call this morning.
展开▼
机译：达伯印度公司计划在今年最后一个季度推出印度草药护肤系列的计划可能会推迟数月，快速消费品公司以超过20.3亿卢比的价格收购了Fern Care Pharma，并计划使其成为其第五大品牌Sunil先生。据信，达布尔印度公司首席执行官杜格（Duggal）今天上午在电话会议上向投资者做了解释。
展开▼
